Low-Dose THC Does Not Reliably Increase Libido
There is insufficient high-quality evidence to recommend low-dose THC for increasing libido, and the available data suggest dose-dependent effects that are inconsistent and potentially harmful.
Evidence Assessment
The provided evidence base contains no guidelines or FDA drug labels addressing THC's effects on libido. The available research is limited to:
One 2020 systematic review 1 examining cannabinoids and female sexual function, which found dose-dependent effects where low doses "generally facilitate or have no effect but high doses inhibit" sexual desire and receptivity. However, this review acknowledged that "more research is needed" and that "whether the effect is positive or negative along dose and species lines requires more study."
Animal studies from 1981 2 showing THC stimulated sexual behaviors in female hamsters—data that cannot be extrapolated to humans given the 40+ year gap and species differences.
A 2019 survey study 3 reporting subjective improvements in sexual experience among cannabis users, but this was an uncontrolled convenience sample of self-selected heavy users (over one-third used cannabis daily), introducing substantial selection and recall bias.
Critical Limitations
Lack of Clinical Trial Data
No randomized controlled trials have evaluated THC specifically for libido enhancement. The cancer-focused ASCO guidelines 4 discuss THC's pharmacology and adverse effects but make no mention of sexual function or libido as an outcome.
Dose-Response Uncertainty
The 2020 review 1 indicates effects are dose-dependent, but "low-dose" is not clearly defined in the literature, and individual responses vary widely based on:
- Route of administration (oral absorption 4-12% vs inhaled 10-35%) 4
- Metabolism via CYP2C19 polymorphisms 4
- Adipose tissue accumulation and gradual release 4
Significant Safety Concerns
Even at therapeutic doses, THC causes:
- Psychoactive effects: euphoria, drowsiness, dizziness, vertigo, hallucinations, mood changes 4
- Cardiovascular risks: Daily cannabis use increases coronary heart disease (2.0% vs 0.9%), myocardial infarction (1.7% vs 1.3%), and stroke (2.6% vs 1.0%) 5
- Psychiatric risks: High-potency cannabis increases psychotic symptoms (12.4% vs 7.1%) and generalized anxiety disorder (19.1% vs 11.6%) 5
- Addiction potential: 29% of medical cannabis users meet criteria for cannabis use disorder 5
Clinical Recommendation
Do not recommend low-dose THC for libido enhancement. The evidence is insufficient, the definition of "low-dose" is unclear, individual responses are unpredictable, and the risks—including cardiovascular events, psychiatric symptoms, and substance use disorder—outweigh any potential and unproven benefits for sexual function.
If Patients Are Already Using THC
For patients using cannabis who report sexual benefits, counsel on harm reduction 5:
- Avoid concurrent alcohol or benzodiazepines
- Use the lowest effective dose
- Avoid driving or operating machinery
- Monitor for adverse cardiovascular and psychiatric effects
- Screen for cannabis use disorder (present in 29% of medical users)
Alternative Approaches
Address underlying causes of decreased libido through evidence-based interventions:
- Evaluate for hormonal deficiencies
- Assess medications that may impair sexual function
- Screen for depression and anxiety
- Consider relationship or psychological counseling
- Review cardiovascular health and metabolic factors
The 2025 JAMA review 5 explicitly states that "evidence from randomized clinical trials does not support the use of cannabis or cannabinoids for most conditions for which it is promoted," and libido enhancement falls squarely into this category of unproven indications.